Clinical trial · Observational
Real World Study of Diagnosis and First-line Treatment Among Patients With Cancer of Unknown Primary in China
NCT04952103CI-TRIAL-00052562unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is a prospective, real world study.The objective is to observe the diagnosis and first-line treatment of Chinese patients with cancer of unknown primary, and collect the clinicopathological characteristics, treatment outcomes, survival and other data of the patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer of Unknown Primary Site | Malignant Neoplasm of Unknown Primary | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| no intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Progression-free survival (PFS)
- timeFrame
- 8 months
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Had a diagnosis of cancer of unknown primary (CUP) after a standard evaluation . * Prepared to receive first-line therapy for CUP Exclusion Criteria: * Patients who had previously received systemic therapy for CUP * Previous history of other cancers, except cervix cancer or basal cell carcinoma of the skin that has been cured * The investigator considered that there were contraindications to treatment or were not appropriate to participate in this study
References
Publications (0)
Data not yet available
No reference posted for this study.